Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00519337 · ClinicalTrials.gov registry record · Phase 4
Impact of Ascorbic Acid on Post-Cardiothoracic Surgery Inflammation
A Phase 4 study of Inflammation and Cardiac Surgery, sponsored by Hartford Hospital.
- Completed
- Registry status
- Phase 4
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT00519337 is a Phase 4 study of Inflammation and Cardiac Surgery that has completed, run by Hartford Hospital. The registered enrollment target is 25 participants, below the 288-participant average among 132 other Inflammation trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00519337, a Phase 4 study of Inflammation and Cardiac Surgery, has completed, sponsored by Hartford Hospital.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to see if ascorbic acid (Vitamin-C) therapy will reduce inflammation following heart surgery.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Ascorbic acid
Study Locations (1)
Connecticut
- Hartford Hosptial - Hartford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2008-10 |
| Est. Completion | 2011-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00519337
The ClinicalTrials.gov registry entry for NCT00519337 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 288-participant average among 132 other Inflammation trials with a reported enrollment target (91% lower). The listed sponsor is Hartford Hospital, which has 75 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Inflammation appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT00519337 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT00519337 about?
NCT00519337 is a clinical study titled "Impact of Ascorbic Acid on Post-Cardiothoracic Surgery Inflammation". The purpose of this study is to see if ascorbic acid (Vitamin-C) therapy will reduce inflammation following heart surgery.
What is the current status of trial NCT00519337?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 25 participants. The study started on 2008-10. Estimated completion is 2011-04.
What conditions does trial NCT00519337 study?
This clinical trial studies the following conditions: Inflammation, Cardiac Surgery.
What interventions are being tested in trial NCT00519337?
The interventions under investigation include: Placebo (DRUG), Ascorbic acid (DRUG).
Who is sponsoring clinical trial NCT00519337?
This trial is sponsored by Hartford Hospital, which has 75 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00519337 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Inflammation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Skin Barrier Function and Inflammation in Aging: The BIA Study
RECRUITING · Phase 4
-
Systemic Immunomodulatory Effects and Pharmacogenetics of Atorvastatin in Early Atherosclerosis
COMPLETED · Phase 4
-
Suvorexant on Sleep Disturbance in Patients With Chronic Insomnia and Suboptimally Controlled Type 2 Diabetes
COMPLETED · Phase 4
-
Efficacy of Ketorolac 0.4% in Prostaglandin Suppression
COMPLETED · Phase 4
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
Reducing Suicide Risk Among Aging Caregivers of Persons With AD/ADRD
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.